Literature DB >> 24497691

Cutaneous metastasis from testicular germ cell tumour.

Anjana Joel1, Amit Dilip Bhatt1, Abraham Samuel1, Raju Titus Chacko1.   

Abstract

The skin is an unusual site of metastases from solid organ malignancies. We report the case of a patient with a malignant mixed non-seminomatous germ cell tumor of the testis, presenting with cutaneous metastasis, which was treated with salvage chemotherapy.

Entities:  

Keywords:  Cutaneous metastasis; germ cell tumor; salvage chemotherapy

Year:  2014        PMID： 24497691      PMCID： PMC3897063          DOI： 10.4103/0970-1591.124215

Source DB:  PubMed          Journal:  Indian J Urol        ISSN： 0970-1591


  12 in total

1.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

Authors: 
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

2.  Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).

Authors:  R J Motzer; N L Geller; C C Tan; H Herr; M Morse; W Fair; J Sheinfeld; P Sogani; P Russo; G J Bosl
Journal:  Cancer       Date:  1991-03-01       Impact factor: 6.860

Review 3.  Cutaneous metastasis of testicular choriocarcinoma, diagnosed by fine-needle aspiration cytology: a rare case report and review of the literature.

Authors:  Bita Geramizadeh; Hanieh Rad
Journal:  Indian J Pathol Microbiol       Date:  2012 Jul-Sep       Impact factor: 0.740

4.  Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.

Authors:  J W Moul; W F McCarthy; E B Fernandez; I A Sesterhenn
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

5.  Fine needle aspiration cytology of cutaneous metastases.

Authors:  C V Reyes; J A Jensen; A M Eng
Journal:  Acta Cytol       Date:  1993 Mar-Apr       Impact factor: 2.319

6.  Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.

Authors:  C Bokemeyer; K Oechsle; F Honecker; F Mayer; J T Hartmann; C F Waller; I Böhlke; C Kollmannsberger
Journal:  Ann Oncol       Date:  2007-11-15       Impact factor: 32.976

7.  OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.

Authors:  Timothy D Jones; Thomas M Ulbright; John N Eble; Lee Ann Baldridge; Liang Cheng
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

8.  Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal.

Authors:  Sadia Saeed; Connie A Keehn; Michael B Morgan
Journal:  J Cutan Pathol       Date:  2004-07       Impact factor: 1.587

9.  Late relapse of testicular cancer.

Authors:  J Baniel; R S Foster; R Gonin; J E Messemer; J P Donohue; L H Einhorn
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

10.  Update on late relapse of germ cell tumor: a clinical and molecular analysis.

Authors:  David W George; Richard S Foster; Robert A Hromas; Kent A Robertson; Gail H Vance; Thomas M Ulbright; Troy A Gobbett; Devan J Heiber; Nyla A Heerema; Heather C Ramsey; Virginia C Thurston; Sin-Ho Jung; Jianzhao Shen; David E Finch; Mark R Kelley; Lawrence H Einhorn
Journal:  J Clin Oncol       Date:  2003-01-01       Impact factor: 44.544
View more
  1 in total

1.  Primary cutaneous mucinous carcinoma of the scrotum: A rare tumor at a rare site - A case report and review of literature.

Authors:  Olajide Olusegun Abiola; Gbemi H Ano-Edward; Olutunde A Oluwumi; Mathew E Lasisi
Journal:  Urol Ann       Date:  2019-11-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.